Phenotypic characteristics of early-onset autosomal-dominant type 2 diabetes unlinked to known maturity-onset diabetes of the young (MODY) genes

Diabetes Care

Volumn 22, Issue 2, 1999, Pages 253-261

  Doria, Alessandro ^a,b   Yang, Yadong ^a,b   Malecki, Maciej ^a,b,c   Scotti, Susan ^a   Dreyfus, Jill ^a   O'Keeffe, Cheryl ^a   Orban, Tihamer ^a,b   Warram, James H ^a   Krolewski, Andrzej S ^a,b  

^a JOSLIN DIABETES CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CHOLESTEROL BLOOD LEVEL; FEMALE; HUMAN; HYPERTENSION; INSULIN TREATMENT; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MATURITY ONSET DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PHENOTYPE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGE OF ONSET; BLOOD GLUCOSE; BODY WEIGHT; CHOLESTEROL; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DNA-BINDING PROTEINS; FAMILY; FEMALE; GENES, DOMINANT; GLUCOSE INTOLERANCE; HEPATOCYTE NUCLEAR FACTOR 1; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HEPATOCYTE NUCLEAR FACTOR 1-BETA; HUMANS; INSULIN; MALE; MIDDLE AGED; NUCLEAR PROTEINS; OBESITY; PHENOTYPE; TRANSCRIPTION FACTORS; TRIGLYCERIDES;

EID: 0032956493     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.2.253     Document Type: Article

References (47)

1. Warram JH, Rich SS, Krolewski AS: Epidemiology and genetics of diabetes mellitus. In Joslin's Diabetes Mellitus. 13th ed. Kahn CR, Weir G, Eds. Philadelphia, Lea & Febiger, 1994, p. 201-215
2. Kahn CR: Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 43:1066-1084, 1994
3. Kahn CR, Vicent D, Doria A: Genetics of non-insulin-dependent (type II) diabetes mellitus. Ann Rev Med 47:509-531, 1996
4. Tattersall RB, Fajans SS: A difference between the inheritance of classical juvenile-onset and maturity-onset type diabetes of young people. Diabetes 24:44-53, 1974
5. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Thanh T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Brostow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick M: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71, 1994
6. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G: Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789-792, 1995
7. Froguel P, Vaxillaire M, Sun F, Velho G, Zouali H, Butel MO, Lesage S, Vionnet N, Clement K, Fougerousse F, Tanizawa Y, Weissenbach J, Beckmann JS, Lathrop GM, Passa P, Permutt MA, Cohen D: Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature 356:162-164, 1992
8. Hattersley AT, Turner RC, Permutt MA, Patel P, Tanizawa Y, Chiu KC, O'Rahilly S, Watkins PJ, Wainscoat JS: Linkage of type 2 diabetes to the glucokinase gene. Lancet 339:1307-1310, 1992
9. Vionnet N, Stoffel M, Takeda J, Yasuda K, Bell GI, Zouali H, Lesage S, Velho G, Iris F, Passa P, Froguel P, Cohen D: Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus. Nature 356:721-722, 1992
10. Yamagata K, Oda N, Kaisaki J, Menzel S, Furuta H, Vaxillaire M, Southam L, Cox RD, Lathrop GM, Boriraj VV, Chen X, Cox NJ, Oda Y, Yano H, Le Beau MM, Yamada S, Nishigon H, Takeda J, Fajans SS, Hattersley AT, Iwasaki N, Hansen T, Pedersen O, Polonsky KS, Turner RC, Velho G, Chevre JC, Froguel P, Bell GI: Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young. Nature 384:455-458, 1996
11. Yamagata K, Furuta H, Oda N, Kaisaki PJ, Menzel S, Cox NJ, Fajans SS, Signorini S, Stoffel M, Bell GI: Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young. Nature 384:458-460, 1996
12. Stoffers DA, Ferrer J, Clarke WL, Habener JF: Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat Genet 17:138-139, 1997
13. Horikawa Y, Iwasaki N, Hara M, Furuta H, Hinokio Y, Cockbum BN, Lindner T, Yamagata K, Ogata M, Tomonaga O, Kuroki H, Kasahara T, Iwamoto Y, Bell GI: Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. Nat Genet 17:384-385, 1997
14. Yamada S, Nishigori H, Onda H, Takahashi K, Kitano N, Morikawa A, Takeuchi T, Takeda J: Mutations in the hepatocyte nuclear factor-1alpha gene (MODY3) are not a major cause of late-onset NIDDM in Japanese subjects. Diabetes 46:1512-1513, 1997
15. Urhammer SA, Rasmussen SK, Kaisaki PJ, Oda K, Yamagata K, Moller AM, Fridberg M, Hansen L, Hansen T, Bell GI, Pedersen O: Genetic variation in the hepatocyte nuclear factor-1 alpha gene in Danish Caucasians with late-onset NIDDM. Diabetologia 40:473-475, 1997
16. Moller AM, Urhammer SA, Dalgaard LT, Reneland R, Berglund L, Hansen T, Clausen JO, Lithell H, Pedersen O: Studies of the genetic variability of the coding region of the hepatocyte nuclear factor-4 alpha in Caucasians with maturity onset NIDDM. Diabetologia 40:980-983, 1997
17. Velho G, Froguel P, Clement K, Pueyo ME, Rakotoambinina B, Zouali H, Passa P, Cohen D, Robert JJ: Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young. Lancet 340:444-448, 1992
18. Lehto M, Tuomi T, Mahtani MM, Widen E, Forsblom C, Sarelin L, Gullstrom M, Isomaa B, Lehtovirta M, Hyrkko A, Kanninen T, Orho M, Manley S, Turner RC, Brettin T, Kirby A, Thomas J, Duyk G, Lander E, Taskinen MR, Groop L: Characterization of the MODY3 phenotype: early-onset diabetes caused by an insulin secretion defect. J Clin Invest 99:582-591, 1997
19. Herman WH, Fajans SS, Ortiz FJ, Smith MJ, Sturis J, Bell GI, Polonsky KS, Halter JB: Abnormal insulin secretion, not insulin resistance, is the genetic or primary defect of MODY in the RW pedigree. Diabetes 43:40-46, 1994
20. O'Rahilly S, Spivey RS, Holman RR, Nugent Z, Clark A, Turner RC: Type II diabetes of early onset: a distinct clinical and genetic syndrome? Br Med J 294:923-928, 1987
21. Vague P, Lassmann V, Grosset C, Vialettes B: Type II diabetes in young subjects: a study of 90 unrelated cases. Diabete Metab 13:92-98, 1987
22. O'Rahilly S, Turner RC: Early-onset type 2 diabetes vs maturity-onset diabetes of the youth: evidente for the existence of two discrete diabetic syndromes. Diabet Med 5:224-229, 1988
23. Harris MI: Impaired glucose tolerance in the U.S. population. Diabetes Care 12:464-474, 1989
24. Krolewski AS, Laffel LMB, Krolewski M, Quinn M, Warram JH: Glycated hemoglobin and risk of microalbummuria in patients with insulin-dependent diabetes mellitus. N Engl J Med 332:1252-1255, 1995
25. Grubin CE, Daniels T, Toivola B, Landin-Olsson M, Hagopian WA, Li L, Karlsen AE, Boel E, Michelsen B, Lemmark A: A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 37:344-350, 1994
26. Christie MR, Vohra G, Champagne D, Delovitch TL: Distinct antibody specificities to a 64-kD islet cell antigen in type I diabetes as revealed by trypsin treatment. J Exp Med 172:789-794, 1990
27. Yang Y, Antonellis A, Malecki M, Wantman M, Warram JH, Krolewski AS: Mutation screening of the HNF-1α gene in North American MODY families (Abstract). Am J Hum Genet 61 (Suppl.):A352, 1997
28. Rothman KJ: Modern Epidemiology. Boston, MA, Little, Brown & Company, 1986
29. Vaxillaire M, Boccio V, Philippi A, Vigouroux C, Terwilliger J, Passa P, Beckmann JS, Velho G, Lathrop GM, Froguel P: A gene for maturity onset diabetes of the young maps to chromosome 12q. Nat Genet 9:418-423, 1995
30. Velho G, Vaxillaire M, Boccio V, Charpentier G, Froguel P: Diabetes complications in NIDDM kindreds linked to the MODY3 locus on chromosome 12 q. Diabetes Care 19:915-919, 1996
31. Reaven GM: Banting Lecture 1988: role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
32. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR: Role of glucose and insulin-resistance in the development of type II diabetes mellitus: results of a 25-years follow-up study. Lancet 340:925-929, 1992
33. Gulli G, Ferrannini E, Stern M, Haffner S, DeFronzo RA: The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes 41:1575-1586, 1992
34. Knowler WC, Pettitt DJ, Saad MF, Bennett PH: Diabetes mellitus in Pima Indians: incidence, risk factors and pathogenesis. Diabetes Meteb Rev 6:1-27, 1990
35. Frayling TM, Bulamn MP, Ellard S, Appleton M, Dronsfield MJ, Mackie AD, Baird JD, Kaisaki PJ, Yamagata K, Bell GI, Bain SC, Hattersley AT: Mutations in the hepatocyte nuclear factor-1alpha gene are a common cause of maturity-onset diabetes of the young in the U.K. Diabetes 46:720-725, 1997
36. Fajans SS: Heterogeneity of insulin secretion in type II diabetes. Diabetes Metab Rev 2:347-361, 1986
37. Turner R, Stratton I, Horton V, Manley S, Zimmet P, Mackay IR, Shattock M, Bottazzo GF, Holman R: UKPDS 25:autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. Lancet 350:1288-1293, 1997
38. Elbein SC, Wegner K, Miles C, Yu L, Eisenbarth G: The role of late-onset autoimmune diabetes in white familial. NIDDM pedigrees. Diabetes Care 20:1248-1251, 1997
39. Clark A, Wells CA, Buley ID, Cruickshank JK, Vanhegan RI, Matthews DR, Cooper GJ, Holman RR, Turner RC: Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res 9:151-159, 1988
40. Isomaa B, Henricsson, Lehto M, Forsblom C, Karanko S, Sarelin L, Haggblom M, Groop L: Chronic diabetic complications in patients with MODY3 diabetes. Diabetologia 41:467-473, 1998
41. DCCT Research Group: The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
42. Groop L, Ekstrand A, Forsblom C, Widen E, Groop PH, Teppo AM, Eriksson J: Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36:642-647, 1993
43. Yip J, Mattock MB, Morocutti A, Sethi M, Trevisan R, Viberti GC: Insulin resistance in insulin-dependent diabetic patients with microalbuminuria. Lancet 342:883-887, 1993
44. Pyorala K: Relationship of glucose tolerance and plasma insulin to the incidence of coronary artery disease: results from two population studies in Finland. Diabetes Care 2:131-141, 1979
45. Ducimetiere P, Eschwege E, Papoz L, Richard JL, Claude JR, Rosselin G: Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary artery disease mortality in a middle-aged population. Diabetologia 19:205-210, 1980
46. Stern MP: Diabetes and cardiovascular disease: the "common soil" hypothesis. Diabetes 44:369-374, 1995
47. Velho G, Benque-Blanchet F, Vaxillaire M, Pontoglio, M, Froguel P, Friedlander G, Prie' D: Renal proximal tubular defects associated to the MODY3 phenotype (Abstract). Diabetologia 41 (Suppl. 1):A108, 1998